the study physician attributed the death to pre-existing coronary artery disease unrelated to the drug, but the FDA's Pharmacy Compounding Advisory Committee cited this "unresolved cardiac signal" in December 2024 as a reason to keep the compound off the approved compounding list
Because of that uncertainty, the FDA labelling recommends weighing the benefits of breastfeeding alongside the mother's need for Zepbound and any possible effects on the baby
look no further than Blue Cross and communication around coming back and saying that through employers, theyll continue to cover it if you have diabetes, but they wont cover it if you have obesity because the the information, the data for diet and exercise is so strong
The ideal time to get a DEXA scan is before starting a GLP-1 medication
I dug through the trial numbers and the pricing
Bend, Oregon Weight Loss Clinics: Profiles Bend offers several clinics with varying approaches to weight management